Remember the pps is always subjective. Beauty is in the eyes of the beholder. So you are right that it will take a GNBT positive balance sheet on a 10-Q/K to force the pps to be in sync with the true GNBT value. The current balance sheets have not inspired a higher pps even though the GNBT potential is massive. I guess that investors want substance not possibilities.
(2)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links